# Acadia Pharmaceuticals

> develop neurological disorder therapies

Business model and tags: B2C, Has physical offices, Publicly traded, Pharma & life sciences, Multi-site, International operations, Has in-house R&D, Handles regulated data

## About Acadia Pharmaceuticals

Develop and commercialize FDA-approved treatments for neurological disorders, focusing on underserved diseases like Parkinson's psychosis and Rett syndrome.

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: san diego, california, United States
- **Founded**: 1993
- **Revenue**: $1.1B (FY2025, publicly reported)
- **Website**: [acadia.com](https://acadia.com/)
- **LinkedIn**: [linkedin.com/company/acadia-pharmaceuticals](https://www.linkedin.com/company/acadia-pharmaceuticals)

## Acadia Pharmaceuticals at a glance

Acadia Pharmaceuticals is a B2C company in the Pharmaceutical Manufacturing industry, headquartered in san diego, california, United States.

Acadia Pharmaceuticals was founded in 1993.

Acadia Pharmaceuticals has 1,001–5,000 employees.

Acadia Pharmaceuticals's revenue is $1.1B (FY2025, publicly reported).

## Frequently asked questions about Acadia Pharmaceuticals

### What is Acadia Pharmaceuticals's revenue?

Acadia Pharmaceuticals's revenue is $1.1B (FY2025, publicly reported).

### How many employees does Acadia Pharmaceuticals have?

Acadia Pharmaceuticals has 1,001–5,000 employees.

### Where is Acadia Pharmaceuticals headquartered?

Acadia Pharmaceuticals is headquartered in san diego, california, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/acadia-pharmaceuticals
